Safety and antibody immune response of CHP-NY-ESO-1 vaccine combined with poly-ICLC in advanced or recurrent esophageal cancer patients

2021 ◽  
Author(s):  
Takeshi Ishikawa ◽  
Shinichi Kageyama ◽  
Yoshihiro Miyahara ◽  
Tetsuya Okayama ◽  
Satoshi Kokura ◽  
...  
Keyword(s):  
Immune Response ◽  
Esophageal Cancer ◽  
Cancer Patients

Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccination

2008 ◽  
Vol 123 (10) ◽  
pp. 2362-2369 ◽  
Author(s):  
Hisashi Wada ◽  
Eiichi Sato ◽  
Akiko Uenaka ◽  
Midori Isobe ◽  
Ryohei Kawabata ◽  
...  
Keyword(s):  
Immune Response ◽  
Esophageal Cancer ◽  
Cancer Patients

Self-expandable Metallic Stent Insertion for Nonresectable Esophageal Cancer Patients.

2001 ◽  
Vol 52 (2) ◽  
pp. 75-81
Author(s):  
Hideo Shimada ◽  
Osamu Chino ◽  
Takayuki Nishi ◽  
Hikaru Tanaka ◽  
Yoshifumi Kise ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Cancer Patients ◽  
Stent Insertion ◽  
Metallic Stent ◽  
Expandable Metallic Stent

scholarly journals 248P Substantial RUNX3 expression and co-existence with EZH2 in esophageal cancer: a new finding in Indian esophageal cancer patients

2016 ◽  
Vol 27 ◽  
pp. ix78
Author(s):  
A.U. Rehman ◽  
M.A. Iqbal ◽  
S. Saikia ◽  
P.K. Mishra ◽  
S.S. Saluja ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Cancer Patients ◽  
New Finding

scholarly journals An in-silico assessment of the dosimetric benefits of MR-guided radiotherapy for esophageal cancer patients

2021 ◽  
Author(s):  
M.R. Boekhoff ◽  
I.L. Defize ◽  
A.S. Borggreve ◽  
R. van Hillegersberg ◽  
A.N.T.J. Kotte ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Cancer Patients ◽  
In Silico
Sign in / Sign up

Export Citation Format

Share Document